KIMBERLY HALLA: Open Payments
NPI 1427406719 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$82,093 in 138 payments from 10 companies in 2025. Trend: 2023 $62,752 · 2024 $68,304 · 2025 $82,093
Speaker / faculty: $51,360Travel & lodging: $22,552Speaker / faculty: $3,255Food & beverage: $2,728Consulting: $2,025Education: $173
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 65 | $52,843 |
| Genmab U.S., Inc. | 23 | $12,000 |
| PFIZER INC. | 14 | $7,770 |
| Eisai Inc. | 19 | $5,742 |
| Merck Sharp & Dohme LLC | 6 | $3,127 |
| AstraZeneca Pharmaceuticals LP | 3 | $221 |
| ABBVIE INC. | 5 | $170 |
| SEAGEN INC. | 1 | $95 |
| Myriad Genetic Laboratories, Inc. | 1 | $87 |
| On Target Laboratories, Inc | 1 | $38 |
Products named: JEMPERLI, Tivdak, ZEJULA, Lenvima, Epkinly, KEYTRUDA, LYNPARZA, ELAHERE.
Industry payments across NC — which companies pay providers there.
